by Lyla El-Fayomi | May 16, 2025
In this edition of RMNU🔬, we’re keeping up with multiple research advances in the vision repair field. Also, Vertex Pharmaceuticals is dropping a big therapeutic from their portfolio, and Longeveron has a new publication. Of course, yet another round of updates on...
by CCRM Australia | Apr 21, 2025
This post was written by Tavin Fonseka (see LinkedIn page) with supervision by Dr. Chih Wei Teng. Imagine a world where injuries that once ended careers became nothing more than mere setbacks. Athletes will heal faster, stronger, and with a greater resiliency...
by Lyla El-Fayomi | Apr 16, 2025
A brief recap You might recall Johanne Provost’s story, which I covered in the September edition of RMNU🔬. New details have since emerged regarding the specifics of her disease: Ms. Provost had been suffering from a rare autoimmune disease – lichen planus – that...
by Lyla El-Fayomi | Mar 26, 2025
Some big trends to discuss this month, as well as one-off headlines. I have clinical updates on epilepsy, tooth regeneration and Parkinson’s – a disease area quickly becoming an RMNU🔬 staple, given all the movement in this field! Read on, bookmark for later, or send...
by Cal Strode | Mar 11, 2025
“Every administration has its headwinds and tailwinds” said Tim Hunt, CEO, Alliance for Regenerative Medicine (ARM), when examining the impact of the two most recent U.S. administrations at ARM’s 2025 State of the Industry Briefing in January. Credit: Alliance for...
by Laya Kiani | Mar 6, 2025
The biotechnology sector has always been a hub of innovation, consistently pushing the boundaries of scientific and technological advancements. However, transforming novel discoveries into viable market-ready solutions requires substantial financial backing. Among the...
Comments